CHINA NATURAL RESOURCES INC (CHNR)
VGG2110U1176 - Common Stock
Taking everything into account, CHNR scores 0 out of 10 in our fundamental rating. CHNR was compared to 156 industry peers in the Metals & Mining industry. Both the profitability and financial health of CHNR have multiple concerns. CHNR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CHNR has reported negative net income.
In the past year CHNR has reported a negative cash flow from operations.
CHNR had negative earnings in 4 of the past 5 years.
CHNR had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
CHNR's Return On Assets of -6.56% is on the low side compared to the rest of the industry. CHNR is outperformed by 66.67% of its industry peers.
Looking at the Return On Equity, with a value of -65.92%, CHNR is doing worse than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.56% | ||
| ROE | -65.92% | ||
| ROIC | N/A |
ROA(3y)-5.85%
ROA(5y)-123.23%
ROE(3y)-28.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHNR has a Gross Margin of 32.53%. This is in the better half of the industry: CHNR outperforms 75.64% of its industry peers.
In the last couple of years the Gross Margin of CHNR has grown nicely.
The Profit Margin and Operating Margin are not available for CHNR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.01%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CHNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHNR has been increased compared to 1 year ago.
The number of shares outstanding for CHNR has been increased compared to 5 years ago.
CHNR has a better debt/assets ratio than last year.
2.2 Solvency
CHNR has an Altman-Z score of -1.32. This is a bad value and indicates that CHNR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.32, CHNR is doing worse than 87.82% of the companies in the same industry.
A Debt/Equity ratio of 1.24 is on the high side and indicates that CHNR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.24, CHNR is doing worse than 90.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.32 |
ROIC/WACCN/A
WACC8.12%
2.3 Liquidity
CHNR has a Current Ratio of 0.62. This is a bad value and indicates that CHNR is not financially healthy enough and could expect problems in meeting its short term obligations.
CHNR has a Current ratio of 0.62. This is amonst the worse of the industry: CHNR underperforms 92.31% of its industry peers.
A Quick Ratio of 0.61 indicates that CHNR may have some problems paying its short term obligations.
The Quick ratio of CHNR (0.61) is worse than 85.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for CHNR have decreased strongly by -106.83% in the last year.
CHNR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -52.83%.
Measured over the past years, CHNR shows a very negative growth in Revenue. The Revenue has been decreasing by -48.34% on average per year.
EPS 1Y (TTM)-106.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-645.97%
Revenue 1Y (TTM)-52.83%
Revenue growth 3Y-48.33%
Revenue growth 5YN/A
Sales Q2Q%-24.12%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHNR. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CHNR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CHINA NATURAL RESOURCES INC
NASDAQ:CHNR (12/20/2024, 8:02:19 PM)
0.5483
-0.01 (-2.18%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners0.2%
Inst Owner Change-82.22%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.41M
Analysts0
Price TargetN/A
Short Float %1.28%
Short Ratio1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.41 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.7 | ||
| P/tB | 1.05 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.23
BVpS0.79
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.56% | ||
| ROE | -65.92% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.53% | ||
| FCFM | N/A |
ROA(3y)-5.85%
ROA(5y)-123.23%
ROE(3y)-28.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.01%
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0.24% | ||
| Cap/Sales | 0.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | -1.32 |
F-Score3
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)4.17%
Cap/Depr(5y)5.83%
Cap/Sales(3y)0.24%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-645.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-52.83%
Revenue growth 3Y-48.33%
Revenue growth 5YN/A
Sales Q2Q%-24.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y87.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.67%
OCF growth 3YN/A
OCF growth 5YN/A